The University of Chicago Header Logo

Connection

Rudolph Navari to Antineoplastic Agents, Alkylating

Back to Details
This is a "connection" page, showing publications Rudolph Navari has written about Antineoplastic Agents, Alkylating.
Rudolph Navari
Connection Strength
0.058
Antineoplastic Agents, Alkylating
  1. A phase II trial of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier Oncology Group study. Support Care Cancer. 2005 Jul; 13(7):529-34.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.